You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Solid Insulation business and improved pricing help Owens Corning (OC) to post higher fourth-quarter 2018 earnings. Significant volume decline in Composites and Roofing business offsets the positives.
Although Universal Forest Products' (UFPI) Q4 numbers are lower than expected, its quarterly results improve on a year-over-year basis, given improved product mix, margins and operating efficiencies.
Although Eversource Energy's (ES) fourth-quarter earnings and revenues lag estimates, the company distributes higher volumes of natural gas in the reported quarter.
Green Dot (GDOT) Q4 results benefit from strong adjusted EBITDA growth, interest income from the investment of cash deposits held at Green Dot Bank and lower effective tax rate.
Although WPX Energy's (WPX) fourth-quarter earnings and revenues miss estimates, it continues to increase U.S. oil production from Delaware and Williston Basin assets.
Sempra Energy's (SRE) Oncor buyout is likely to boost earnings growth in the fourth quarter. Temperature is expected to act as a catalyst for the company's quarterly result.
ONE Gas' (OGS) fourth-quarter revenues are better than expected due to higher consumption of natural gas, backed by the expansion of its customer base.
Although the rise in daily oil equivalent production will support Gran Tierra's (GTE) bottom line in Q4, the decline in price realization for the commodity is a concern.
Solar Edge (SRE) posts better-than-expected revenues in the fourth quarter of 2018. The company shipped a total of 1.1 Gigawatts (AC) of inverters in the reported quarter.
Agios' (AGIO) label expansion filing eyes an approval of Tibsovo for newly diagnosed acute myeloid leukemia patients with an IDH1 mutation. The drug also gets a priority review tag from the FDA.
Genomic Health's (GHDX) year-over-year rise in revenues, driven by a solid uptick in the United States and internationally, makes us optimistic about the stock.
We are on the verge of the next advancement in mobile networking technology. Sheraz Mian will help you find the industries and the companies that offer the biggest opportunities to profit from this upcoming "revolution".
Zacks.com Most Recent Articles
CVR Partners' (UAN) Earnings and Revenues Rise Y/Y in Q4
Analyst Blog
by Zacks Equity Research
CVR Partners' (UAN) Q4 results gain from higher utilization rates and pricing.
MOS UAN KL SSRM
agriculture basic-materials
Billiton (BBL) is a Great Momentum Stock: Should You Buy?
Tale of the Tape
by Zacks Equity Research
Does Billiton (BBL) have what it takes to be a top stock pick for momentum investors? Let's find out.
BBL
momentum-investor momentum-stocks price-change volume
Owens Corning (OC) Stock Down 5% Despite Q4 Earnings Beat
Analyst Blog
by Zacks Equity Research
Solid Insulation business and improved pricing help Owens Corning (OC) to post higher fourth-quarter 2018 earnings. Significant volume decline in Composites and Roofing business offsets the positives.
OC URI MTH PHM
construction earnings
Zacks Market Edge Highlights: Amazon, Walmart, Alibaba, Facebook and Microsoft
Press Releases
by Zacks Equity Research
Zacks Market Edge Highlights: Amazon, Walmart, Alibaba, Facebook and Microsoft
AMZN BABA FB MSFT WMT
tech-stocks
Universal Forest Products (UFPI) Q4 Earnings Lag, Up Y/Y
Analyst Blog
by Zacks Equity Research
Although Universal Forest Products' (UFPI) Q4 numbers are lower than expected, its quarterly results improve on a year-over-year basis, given improved product mix, margins and operating efficiencies.
FIX UFPI GLDD EME
construction earnings
Wolverine (WWW) Stock Declines 11% Despite Q4 Earnings Beat
Analyst Blog
by Zacks Equity Research
Wolverine's (WWW) bottom line in fourth-quarter 2018 outpaces the Zacks Consensus Estimate. However, management provided a muted outlook for 2019.
NKE DECK SKX WWW
consumer-discretionary earnings retail
Eversource Energy (ES) Misses on Q4 Earnings, Beats Revenues
Analyst Blog
by Zacks Equity Research
Although Eversource Energy's (ES) fourth-quarter earnings and revenues lag estimates, the company distributes higher volumes of natural gas in the reported quarter.
D EXC NEE ES
earnings utilities
IDACORP (IDA) Beats Q4 Earnings Estimates, Adds Customers
Analyst Blog
by Zacks Equity Research
Strong customer growth in Idaho Power's service area drives IDACORP's (IDA) Q4 earnings.
NEE XEL AEP IDA
earnings utilities
Green Dot's (GDOT) Q4 Earnings & Revenues Beat Estimates
Analyst Blog
by Zacks Equity Research
Green Dot (GDOT) Q4 results benefit from strong adjusted EBITDA growth, interest income from the investment of cash deposits held at Green Dot Bank and lower effective tax rate.
NCI FCN GDOT ICFI
business-services
Check Out Gap's (GPS) Probability to Beat Earnings in Q4
Analyst Blog
by Zacks Equity Research
Gap's (GPS) growth initiatives including expansion of omni-channel capabilities are encouraging. However, softness in its flagship brand is a concern.
HD ANF GPS AEO
earnings retail
WPX Energy (WPX) Earnings and Revenues Miss Estimates in Q4
Analyst Blog
by Zacks Equity Research
Although WPX Energy's (WPX) fourth-quarter earnings and revenues miss estimates, it continues to increase U.S. oil production from Delaware and Williston Basin assets.
CNX DVN NBL WPX
earnings oil-energy
Sempra Energy (SRE) to Post Q4 Earnings: Is a Beat in Store?
Analyst Blog
by Zacks Equity Research
Sempra Energy's (SRE) Oncor buyout is likely to boost earnings growth in the fourth quarter. Temperature is expected to act as a catalyst for the company's quarterly result.
PNM ED PCG SRE
earnings utilities
ONE Gas' (OGS) Q4 Earnings Miss Estimates, Revenues Beat
Analyst Blog
by Zacks Equity Research
ONE Gas' (OGS) fourth-quarter revenues are better than expected due to higher consumption of natural gas, backed by the expansion of its customer base.
NFG ATO MDU OGS
earnings utilities
Jack in the Box (JACK) Q1 Earnings & Revenues Beat Estimates
Analyst Blog
by Zacks Equity Research
Jack in the Box's (JACK) comps growth in first-quarter fiscal 2019 can be attributed to an increase in average check growth.
DRI JACK EAT LOCO
earnings restaurants
Gran Tierra (GTE) to Report Q4 Earnings: What's in the Cards?
Analyst Blog
by Zacks Equity Research
Although the rise in daily oil equivalent production will support Gran Tierra's (GTE) bottom line in Q4, the decline in price realization for the commodity is a concern.
PARR GTE ESTE GDP
earnings oil-energy
Donegal Group (DGICA) Incurs Loss in Q4, Revenues Rise Y/Y
Analyst Blog
by Zacks Equity Research
Donegal Group (DGICA) fourth-quarter 2018 reflects lower net premiums written and higher expenses.
MTG RLI DGICA PGR
earnings insurance
SolarEdge (SEDG) Q4 Earnings Miss, Revenues Increase Y/Y
Analyst Blog
by Zacks Equity Research
Solar Edge (SRE) posts better-than-expected revenues in the fourth quarter of 2018. The company shipped a total of 1.1 Gigawatts (AC) of inverters in the reported quarter.
SEDG CSIQ SPWR ENPH
earnings oil-energy
EA's Apex Legends Dethrones Fortnite in Battle Royale Genre
Analyst Blog
by Zacks Equity Research
Electronic Arts' (EA) recent release Apex Legends smashes records of Fortnite and bolsters its position in the battle royale genre.
TCEHY EA ATVI TTWO
consumer-discretionary tech-stocks
Community Health (CYH) Q4 Loss Wider Than Expected, Down Y/Y
Analyst Blog
by Zacks Equity Research
Community Health's (CYH) Q4 results disappoint with loss from decline in admissions, partially offset by lower expenses.
UNH HCA CYH ENSG
medical
Agios' Tibsovo Gets FDA Priority Review in First-Line Cancer
Analyst Blog
by Zacks Equity Research
Agios' (AGIO) label expansion filing eyes an approval of Tibsovo for newly diagnosed acute myeloid leukemia patients with an IDH1 mutation. The drug also gets a priority review tag from the FDA.
AGIO BDSI CELG PRQR
medical
Insperity (NSP) Benefits From Higher Worksite Employee Growth
Analyst Blog
by Zacks Equity Research
Strong staffing market and higher worksite employee growth rate are positives for Insperity (NSP).
OMC RHI NSP ADP
business-services
Medidata's (MDSO) Margins Under Pressure, Competition Rife
Analyst Blog
by Zacks Equity Research
Medidata (MDSO) suffers from cutthroat competition in the clinical trial solutions market at the moment.
MDSO ABT CSII SRDX
medical
Avis Budget (CAR) Beats Q4 Earnings Estimates, Lags Revenues
Analyst Blog
by Zacks Equity Research
Avis Budget (CAR) fourth-quarter 2018 earnings benefit from higher pricing in Americas and lower per unit fleet cost.
CAR NCI FCN ICFI
business-services earnings
Genomic Health (GHDX) Q4 Earnings Beat Estimates, Margins Up
Analyst Blog
by Zacks Equity Research
Genomic Health's (GHDX) year-over-year rise in revenues, driven by a solid uptick in the United States and internationally, makes us optimistic about the stock.
VAR ANGO GHDX CNMD
earnings medical
Synopsys (SNPS) Q1 Earnings & Revenues Surpass Estimates
Analyst Blog
by Zacks Equity Research
Synopsys' (SNPS) first-quarter fiscal 2019 results gain traction from its solid product portfolio and a diverse customer base.
FTNT MEET CVLT SNPS
computers earnings tech-stocks
Alleghany (Y) Q4 Earnings Beat Estimates, Revenues Improve
Analyst Blog
by Zacks Equity Research
Significant level of catastrophe loss ails Alleghany's (Y) Q4 results. However, higher revenues and premium growth are tailwinds.
MTG PGR RLI Y
insurance
IMAX to Report Q4 Earnings: How Are Things Shaping Up?
Analyst Blog
by Zacks Equity Research
IMAX fourth-quarter 2018 results are likely to benefit from solid box office results. However, one-time charges are likely to hurt results.
DIS T SNE IMAX
consumer-discretionary
Bear of the Day: MGM Resorts (MGM)
Bear of the Day
by Kevin Cook
The Zacks Rank nailed this weak bet last May and now the Macau outlook continues to slip
PENN MGM LVS BYD
travel-leisure
Bull of the Day: Tandem Diabetes Care (TNDM)
Bull of the Day
by Kevin Cook
FDA approval of its latest smart insulin pump has revived investor faith in shares that once traded above $300
TNDM MDT
medical
Investing in the Coming Data Revolution
Weekend Wisdom
by Sheraz Mian
We are on the verge of the next advancement in mobile networking technology. Sheraz Mian will help you find the industries and the companies that offer the biggest opportunities to profit from this upcoming "revolution".
earnings